Suzanne Ildstad
Net worth: 12 M $ as of 31/03/2024
Profile
Suzanne T.
Ildstad is the founder of Talaris Therapeutics, Inc. which was founded in 2002.
She held the title of Chief Scientific Officer & Director from 2018 to 2022.
Dr. Ildstad is also the founder of the University of Louisville.
She received her undergraduate degree from the University of Minnesota.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
1.98% | 14/06/2023 | 507,980 ( 1.98% ) | 12 M $ | 31/03/2024 |
Former positions of Suzanne Ildstad
| Companies | Position | End |
|---|---|---|
| University of Louisville | Founder | - |
| TOURMALINE BIO, INC. | Chief Executive Officer | 01/11/2018 |
Training of Suzanne Ildstad
| University of Minnesota | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company, which engages in the development of allogeneic hematopoietic stem cell transplantation. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Wellesley, MA. | Health Technology |
- Stock Market
- Insiders
- Suzanne Ildstad
